CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Dietary Modification - Wheat-Gluten Free

Transient elastography in patients with celiac disease: A noninvasive method to detect liver involvement associated with celiac disease.

Written by CYBERMED LIFE NEWS
facebook Share on Facebook
Abstract Title:

Transient elastography in patients with celiac disease: A noninvasive method to detect liver involvement associated with celiac disease.

Abstract Source:

Scand J Gastroenterol. 2012 Apr 19. Epub 2012 Apr 19. PMID: 22512436

Abstract Author(s):

Sara Massironi, Roberta Elisa Rossi, Mirella Fraquelli, Maria Teresa Bardella, Luca Elli, Marco Maggioni, Serena Della Valle, Matilde Pia Spampatti, Massimo Colombo, Dario Conte

Article Affiliation:

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology Unit 2 , Milan , Italy.

Abstract:

Abstract Background. Liver involvement in celiac disease (CD) is clinically relevant and could require specific treatment in addition to gluten-free diet (GFD). Transient elastography (TE), a noninvasive tool for assessing liver stiffness (LS), has widely been reported as an accurate surrogate marker of liver fibrosis. Aims. To prospectively identify celiac patients with liver involvement by TE and to assess the effect of GFD. Material and methods. Ninety-five histologically confirmed CD patients (24 newly diagnosed) were consecutively evaluated by TE and compared with 146 patients with chronic hepatitis C (HCV) and 54 healthy subjects. Results. LS ranged between 2.8 and 6.7 kPa (median 4.9) in healthy subjects, defining 6.9 kPa as the upper reference limit (2 SD above the mean levels). TE was above 6.9 kPa in 10 (10.5%) CD patients. Median TE values resulted significantly higher in CD patients with hypertransaminasemia than those without [6.1 vs. 4.2 kPa (p<0.01)]. Among the 24 newly diagnosed patients with CD, median TE values declined from 4.4 to 4 kPa, after 6 months of GFD, resulting below 6.9 kPa in 100% of the patients. Conclusions. A subset of CD patients with hypertransaminasemia showed liver involvement by TE. Accordingly, based on its accuracy in predicting liver fibrosis, TE could be used to identify those CD patients suitable for liver biopsy.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.